Morgan Stanley Raises Price Target for AbbVie as Analysts Present Positive Outlook on Company’s Stability and Performance
On October 11, 2023, research analysts at Morgan Stanley raised their price target for AbbVie (NYSE:ABBV) from $189.00 to $193.00. ...